ATE89738T1 - Antientzuendungsmittel. - Google Patents
Antientzuendungsmittel.Info
- Publication number
- ATE89738T1 ATE89738T1 AT89900524T AT89900524T ATE89738T1 AT E89738 T1 ATE89738 T1 AT E89738T1 AT 89900524 T AT89900524 T AT 89900524T AT 89900524 T AT89900524 T AT 89900524T AT E89738 T1 ATE89738 T1 AT E89738T1
- Authority
- AT
- Austria
- Prior art keywords
- inflammatory
- phospholipase
- body tissue
- potent anti
- inhibiting properties
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Resistance Heating (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/122,379 US5266562A (en) | 1987-11-19 | 1987-11-19 | Anti-inflammatory agents |
PCT/US1988/004158 WO1989005147A1 (en) | 1987-11-19 | 1988-11-21 | New anti-inflammatory agents |
EP89900524A EP0397679B1 (de) | 1987-11-19 | 1988-11-21 | Antientzündungsmittel |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE89738T1 true ATE89738T1 (de) | 1993-06-15 |
Family
ID=22402359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89900524T ATE89738T1 (de) | 1987-11-19 | 1988-11-21 | Antientzuendungsmittel. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5266562A (de) |
EP (1) | EP0397679B1 (de) |
JP (1) | JPH03502197A (de) |
AT (1) | ATE89738T1 (de) |
AU (2) | AU2812789A (de) |
DE (1) | DE3881405T2 (de) |
WO (1) | WO1989005147A1 (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01199995A (ja) * | 1988-02-04 | 1989-08-11 | Kyowa Hakko Kogyo Co Ltd | ホスホリパーゼa↓2阻害ペプチド |
US5561220A (en) * | 1991-02-08 | 1996-10-01 | Diatech, Inc. | Technetium-99m labeled peptides for imaging inflammation |
US6019958A (en) * | 1991-02-08 | 2000-02-01 | Diatide, Inc. | Technetium-99m labeled peptides for imaging inflammation |
US5552525A (en) * | 1991-02-08 | 1996-09-03 | Diatech Inc. | Technetium-99m labeled peptides for imaging inflammation |
US5656602A (en) * | 1991-07-04 | 1997-08-12 | Garvan Institute Of Medical Research | PLA2 inhibitory compounds |
AU6156294A (en) * | 1993-03-03 | 1994-09-26 | Teijin Limited | Physiologically active peptide |
BE1006919A3 (nl) * | 1993-03-15 | 1995-01-24 | Ley Marc Jozef Philemon De | Farmaceutisch preparaat op basis van clara celeiwit cc10, en het gebruik daarvan als geneesmiddel en diagnosticum. |
US6288039B1 (en) | 1995-03-07 | 2001-09-11 | George Washington University | Pharmaceutical compositions methods and kits for treatment and diagnosis of breast cancer |
US5696092A (en) * | 1995-03-07 | 1997-12-09 | George Washington University | Methods and compositions for inhibiting metastasis of epithelial cell-derived cancers |
US6509316B2 (en) | 1995-03-07 | 2003-01-21 | George Washington University | Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer |
US6358915B1 (en) * | 1995-03-07 | 2002-03-19 | George Washington University | Methods for inhibiting metastasis |
US5935860A (en) * | 1995-03-07 | 1999-08-10 | The George Washington University | Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia |
US5904144A (en) * | 1996-03-22 | 1999-05-18 | Cytotherapeutics, Inc. | Method for treating ophthalmic diseases |
US6299895B1 (en) | 1997-03-24 | 2001-10-09 | Neurotech S.A. | Device and method for treating ophthalmic diseases |
US6221672B1 (en) | 1996-04-30 | 2001-04-24 | Medtronic, Inc. | Method for determining platelet inhibitor response |
GB9613705D0 (en) * | 1996-06-29 | 1996-08-28 | Mini Agriculture & Fisheries | Novel peptides |
US20030207795A1 (en) * | 1997-05-28 | 2003-11-06 | Pilon Aprile L. | Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
US20060281681A1 (en) * | 1997-05-28 | 2006-12-14 | Pilon Aprile L | Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |
US20040047857A1 (en) * | 1997-05-28 | 2004-03-11 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
US20060025348A1 (en) * | 1997-05-28 | 2006-02-02 | Pilon Aprile L | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
AU2002300876B2 (en) * | 1997-05-28 | 2006-07-13 | Claragen Inc. | Use of Recombinant Human Uteroglobin in Treatment of Inflammatory and Fibrotic Conditions |
US6255281B1 (en) * | 1997-05-28 | 2001-07-03 | Claragen, Inc. And U.S. Government | Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
US7122344B2 (en) * | 1997-05-28 | 2006-10-17 | Claragen, Inc. | Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
WO2000072868A2 (en) * | 1999-06-01 | 2000-12-07 | Prendergast Patrick T | Peptides for therapeutic use |
US20030129186A1 (en) | 2001-07-25 | 2003-07-10 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
EP1558264A4 (de) * | 2002-09-29 | 2009-06-17 | Surmodics Inc | Verfahren für die subretinale verabreichung von therapeutika, einschliesslich steroide; verfahren zur lokalisierung der pharmakodynamischen wirkung an choroid und retina; und relevante verfahren zur behandlung und/oder prävention von retina-erkrankungen |
US20060110428A1 (en) | 2004-07-02 | 2006-05-25 | Eugene Dejuan | Methods and devices for the treatment of ocular conditions |
US8003124B2 (en) * | 2005-04-08 | 2011-08-23 | Surmodics, Inc. | Sustained release implants and methods for subretinal delivery of bioactive agents to treat or prevent retinal disease |
SI1889198T1 (sl) | 2005-04-28 | 2015-02-27 | Proteus Digital Health, Inc. | Farma-informacijski sistem |
EP2063905B1 (de) | 2006-09-18 | 2014-07-30 | Raptor Pharmaceutical Inc | Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen |
WO2008084063A1 (en) * | 2007-01-09 | 2008-07-17 | Fovea Pharmaceuticals | Apparatus for intra-ocular injection |
KR20100056507A (ko) * | 2007-09-11 | 2010-05-27 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 펩티드 pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys의 용도 |
EP2205265A1 (de) * | 2007-09-11 | 2010-07-14 | Mondobiotech Laboratories AG | Verwendung des peptids thymosin beta 4 allein oder in kombination mit cecropin als therapeutisches mittel |
RU2010114034A (ru) * | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Терапевтическое применение нейропептида ei и acth 7-38 и их комбинаций |
NZ588895A (en) | 2008-05-13 | 2012-07-27 | Clarassance Inc | Recombinant human CC10 (rhCC10 aka uteroglobin) and compositions thereof for use in the treatment of nasal rhinitis |
DK2398500T3 (da) | 2009-02-20 | 2019-05-13 | 2 Bbb Medicines B V | Glutathion-baseret lægemiddelafgivelsessystem |
ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
JP2013507373A (ja) * | 2009-10-08 | 2013-03-04 | ニューロテック ユーエスエー, インコーポレイテッド | 被包された細胞ベースの送達系におけるpedfの使用 |
KR101597391B1 (ko) | 2009-10-15 | 2016-02-24 | 클라라산스, 인크. | 인플루엔자 치료용 재조합 사람 cc10 단백질 |
US9168285B2 (en) | 2009-10-15 | 2015-10-27 | Therabron Therapeutics, Inc. | Recombinant human CC10 protein for treatment of influenza and ebola |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
WO2016133560A1 (en) * | 2015-02-16 | 2016-08-25 | Therabron Therapeutics, Inc. | Recombinant human cc10 protein for treatment of influenza and ebola |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4810777A (en) * | 1987-03-04 | 1989-03-07 | The United States Of America As Represented By The Department Of Health And Human Services | Antimicrobial compounds |
DE3850107T2 (de) * | 1987-03-04 | 1995-02-23 | The United States Of America, Represented By The Secretary, U.S. Department Of Commerce, Springfield, Va. | Neue synthetische bioaktive verbindungen und verfahren zur herstellung bioaktiver wirkungen. |
-
1987
- 1987-11-19 US US07/122,379 patent/US5266562A/en not_active Expired - Lifetime
-
1988
- 1988-11-21 DE DE8989900524T patent/DE3881405T2/de not_active Expired - Fee Related
- 1988-11-21 AU AU28127/89A patent/AU2812789A/en active Granted
- 1988-11-21 AU AU28127/89A patent/AU623620B2/en not_active Ceased
- 1988-11-21 WO PCT/US1988/004158 patent/WO1989005147A1/en active IP Right Grant
- 1988-11-21 EP EP89900524A patent/EP0397679B1/de not_active Expired - Lifetime
- 1988-11-21 AT AT89900524T patent/ATE89738T1/de not_active IP Right Cessation
- 1988-11-21 JP JP89500982A patent/JPH03502197A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US5266562A (en) | 1993-11-30 |
DE3881405D1 (de) | 1993-07-01 |
EP0397679A4 (en) | 1990-12-12 |
AU2812789A (en) | 1989-07-05 |
JPH03502197A (ja) | 1991-05-23 |
EP0397679A1 (de) | 1990-11-22 |
WO1989005147A1 (en) | 1989-06-15 |
DE3881405T2 (de) | 1993-09-09 |
EP0397679B1 (de) | 1993-05-26 |
AU623620B2 (en) | 1992-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE89738T1 (de) | Antientzuendungsmittel. | |
ATE96032T1 (de) | Verfahren zur herstellung von aloe-erzeugnissen. | |
ATE55054T1 (de) | Renininhibitoren und verfahren zur anwendung derselben. | |
FR2631228B1 (fr) | Implant intra-oculaire de chambre anterieure | |
NO893400L (no) | Hiv protease inhibitorer egnet for behandling av aids. | |
IT1224499B (it) | Composizioni esaltatrici della permeazione cutanea comprendenti glicerol monooleato | |
DE69028535D1 (de) | Herstellung des vaskulären endothelialen zellwachstumsfaktors | |
AU4053985A (en) | Packing of surgical needle and suture | |
AU3850189A (en) | Phosphonate adducts of olefinic lubricants having enhanced properties | |
DE59509848D1 (de) | Kombinationspräparat zur anwendung bei immunologischen erkrankungen | |
SG139553A1 (en) | 7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereof | |
GB8706141D0 (en) | Treatment of damaged limb | |
NO171269C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter | |
SE8804256L (sv) | Homogen kiselnitridsintrad kropp och foerfarande foer tillverkning av densamma | |
ES2043903T3 (es) | Mezcla de una substancia de efecto trombolitico y de una substancia antitrombotica. | |
DE59709922D1 (de) | Pflaster zur transdermalen anwendung von pergolid | |
DE58905768D1 (de) | Verfahren zur herstellung von zur rektalen und vaginalen anwendung geeigneten praeparaten biologisch aktiver peptide. | |
NO173145C (no) | Fremgangsmaate for behandling av voerter | |
TR22497A (tr) | P-ksilel ve metonolidan tereftalik asit dimetilester uezerinden tereftalik asidin ueretilmesine mahsus usul | |
KR900702227A (ko) | 트랜지스터 점화 시스템의 최종 점화 스테이지 | |
AU2473388A (en) | Treatment of factor viii inhibitors | |
FR2618602B1 (fr) | Source d'electrons | |
NO890293D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo- og pyridobenzo-azepinon-derivater. | |
EP0402857A3 (de) | Verwendung von 17-beta-Cyclopropylaminoandrosten-Derivaten | |
UA25478A (uk) | Спосіб хірургічhої реіhhервації hиркового алотраhсплаhтату реципієhтhими hервовими джерелами |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |